Latest news with #MaximGroup
Yahoo
a day ago
- Business
- Yahoo
Robin Energy prices 763,000 shares at $5.25 in registered direct offering
Robin Energy (RBNE) entered into a securities purchase agreement with several institutional investors to purchase 763,000 common shares at an offering price of $5.25, for gross proceeds of approximately $4M, before deducting commissions and offering expenses, in a registered direct offering. Maxim Group is acting as the sole placement agent for the Offering. Robin Energy currently intends to use the net proceeds from the Offering for working capital and general corporate purposes. The Offering is expected to close on or about June 20, subject to the satisfaction of customary closing conditions. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on RBNE: Disclaimer & DisclosureReport an Issue Robin Energy Ltd. Secures $4.5 Million in Direct Offering Robin Energy Ltd trading resumes Robin Energy Ltd trading halted, volatility trading pause Robin Energy prices 860,000 shares at $5.25 in registered direct offering Robin Energy Ltd. Announces $5.1 Million Direct Offering Sign in to access your portfolio
Yahoo
a day ago
- Business
- Yahoo
Moleculin Biotech prices 16.08M shares at 37c in public offering
Moleculin Biotech (MBRX) announced the pricing of a public offering consisting of 16,080,000 shares of common stock and Series E warrants to purchase up to 48,240,000 shares of its common stock, at a combined public offering price per share of common stock and accompanying Series E warrants of 37c. The Series E warrants will have an exercise price of 37c per share, are exercisable upon stockholder approval, and will expire five years following the initial exercise date. The offering is expected to close on or about June 23, subject to customary closing conditions. Gross proceeds, before deducting placement agent fees and commissions and offering expenses, are expected to be approximately $5.9M. The Company intends to use the net proceeds from the offering to advance Annamycin and its other two drug portfolios through clinical development, advancing the remainder of the existing portfolio through preclinical studies and into INDs or their equivalent, sponsoring research, and for working capital. Roth Capital Partners is acting as exclusive placement agent of the offering. Maxim Group is acting as financial advisor to the Company. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on MBRX: Disclaimer & DisclosureReport an Issue Promising Developments and Regulatory Progress Drive Buy Rating for Moleculin Biotech's Annamycin Moleculin Biotech's Annamycin Pediatric Study Approved by FDA Moleculin Biotech receives FDA feedback on pediatric study plan for Annamycin Moleculin Biotech announces 'What This Means' virtual investor segment Moleculin Biotech assumed with a Buy at H.C. Wainwright Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
4 days ago
- Business
- Business Insider
OceanPal files to sell 9.32M units
Maxim Group is acting as sole book-running manager. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Yahoo
6 days ago
- Business
- Yahoo
BEST SPAC I Acquisition Corp. Announces Closing of $55 Million Initial Public Offering
HONG KONG, June 17, 2025 /PRNewswire/ -- BEST SPAC I Acquisition Corp. (Nasdaq: BSAAU) (the "Company"), a blank check company incorporated as a British Virgin Islands business company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses, today announced the closing of its previously announced initial public offering of 5,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-tenth (1/10) of one Class A ordinary share upon consummation of the Company's initial business combination. The units began trading on the Nasdaq Capital Market ("Nasdaq") under the ticker symbol "BSAAU" on June 13, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols "BSAA" and "BSAAR," respectively. Maxim Group LLC acted as the sole book-running manager for the offering. The Company has granted the underwriter a 45-day option to purchase up to 825,000 additional units at the initial public offering price less the underwriting discount to cover over-allotments, if any. A registration statement on Form S-1 (File No. 333-286237) (the "Registration Statement") relating to the securities to be sold in the initial public offering, as amended, was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on June 12, 2025. The offering was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, by telephone at (212) 895-3745 or by email at syndicate@ or by accessing the SEC's website, This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About BEST SPAC I Acquisition Corp. BEST SPAC I Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. BEST SPAC I Acquisition Corp. intends to focus on businesses in the consumer goods sector. Forward-Looking Statements This press release contains statements that constitute "forward-looking statements," including with respect to the anticipated use of the net proceeds and search for an initial business combination. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Registration Statement and related prospectus filed in connection with the initial public offering with the SEC. Copies are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. View original content: SOURCE BEST SPAC I Acquisition Corp.
Globe and Mail
6 days ago
- Business
- Globe and Mail
Castellum Announces Closing of $5.0 Million Public Offering of Common Stock and Warrants
VIENNA, Va., June 16, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (the 'Company' and 'Castellum') (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, today announced the closing of its previously announced public offering of 4,166,667 Units at a public offering price of $1.20 per Unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The warrants are immediately exercisable at $1.22 per share and will expire 60 days from the date of issuance. The shares of common stock and warrants are immediately separable and were issued separately. Gross proceeds from the offering are approximately $5.0 million before deducting placement agent fees and offering expenses. Castellum intends to use the net proceeds of the offering for working capital and general corporate purposes. Maxim Group LLC acted as the sole placement agent on a reasonable best-efforts basis for the offering. A shelf registration statement on Form S-3 (File No. 333-284205) relating to the securities being offered was previously filed with the U.S. Securities and Exchange Commission (the 'SEC') and became effective on January 24, 2025. The shares of common stock and shares underlying the warrants were offered only by means of a prospectus. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the public offering have been filed with the SEC. A final prospectus supplement and an accompanying prospectus relating to the offering has been with the SEC and is available on the SEC's website at Copies of the final prospectus supplement and accompanying prospectus relating to the public offering may be obtained by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department, or by telephone at (212) 895-3745 or by email at syndicate@ This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Castellum, Inc. (NYSE-American: CTM): Castellum, Inc. (NYSE-American: CTM) is a cybersecurity, electronic warfare, and software engineering services company focused on the federal government - Forward-Looking Statements: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Words such as 'will,' 'would,' 'believe,' and 'expects,' and similar language or phrasing are indicative of forward-looking statements. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company's control, that could cause actual results to differ (sometimes materially) from the results expressed or implied in the forward-looking statements, including, among others: the Company's ability to effectively integrate and grow its acquired companies; its ability to identify additional acquisition targets and close additional acquisitions; the impact on the Company's revenue due to a delay in the U.S. Congress approving a federal budget, operating under a prolonged continuing resolution, government shutdown, or breach of the debt ceiling, as well as the imposition by the U.S. government of sequestration in the absence of an approved budget; the ability of the U.S. federal government to unilaterally cancel a contract with or without cause, and more specifically, the potential impact of the U.S. DOGE Service Temporary Organization on government spending and terminating contracts for convenience. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in Item 1A. 'Risk Factors' section of the Company's recently filed Form 10-Q, Item 1A. "Risk Factors' in the Company's most recent Form 10-K, and other filings with the Securities and Exchange Commission which can be viewed at These risks and uncertainties, or not closing the described potential equity financing in this press release, could cause the Company's actual results to differ materially from those indicated in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise. Contact:
